Publication | Closed Access

FCPR03, a novel phosphodiesterase 4 inhibitor, alleviates cerebral ischemia/reperfusion injury through activation of the AKT/GSK3β/ β-catenin signaling pathway

InflammationNeuroinflammationIschemic StrokeNovel Phosphodiesterase 4MedicineCerebral Ischemia/reperfusion InjuryBrain InjuryNeurologyNeuroprotectionNeuroscienceCerebral Blood FlowReperfusion InjuryPharmacologyCell SignalingIschemic SyndromeMolecular Signaling